BPG is committed to discovery and dissemination of knowledge
Retrospective Study
©Author(s) (or their employer(s)) 2026.
World J Gastrointest Surg. Feb 27, 2026; 18(2): 113103
Published online Feb 27, 2026. doi: 10.4240/wjgs.v18.i2.113103
Figure 1
Figure 1 Comparative gastrointestinal function markers. A: Preoperative/postoperative gastrin level changes; B: Preoperative/postoperative motilin level alterations. aP < 0.05, bP < 0.01 for intra-group vs preoperative; cP < 0.05 for inter-group comparison at same time point. GAS: Gastrin; MT: Motilin.
Figure 2
Figure 2 Serum oncological biomarkers in both patient groups. A: Comparative carcinoembryonic antigen levels before and after surgery; B: Preoperative and postoperative cytokeratin 19 fragment antigen 21-1 level variations across groups; C: Carbohydrate antigen 125 variation pre-surgery vs post-surgery. aP < 0.05, bP < 0.01 for within-group vs baseline; cP < 0.05 for inter-group vs four-port. CA125: Carbohydrate antigen 125; CEA: Carcinoembryonic antigen; Cyfra 21-1: Cytokeratin 19 fragment antigen 21-1.
Figure 3
Figure 3 Comparative analysis of humoral immune responses. A: Preoperative and postoperative immunoglobulin (Ig) A dynamics across study cohorts; B: Temporal changes in IgG concentrations (preoperative vs postoperative); C: IgM level variations before and after surgery. bP < 0.01 for within-group preoperative comparisons; cP < 0.05 for between-group differences relative to four-port group at equivalent timepoints. Ig: Immunoglobulin.